Abstract 783: Gender and Racial Disparities in Stroke Clinical Trials
Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)
DOI: 10.1161/svi270000_783 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von W. H. Windhorst und 4 weiteren Autor:innen.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Strokes are the second-leading cause of death globally, accounting for 6.55 million deaths in 2019. African Americans and Hispanic Americans suffer from strokes at disproportionately higher rates compared to Caucasians. Despite these differences, racial disparities in stroke clinical trials remain understudied, potentially contributing to inequities in the efficacy of stroke care and recovery. This project examines how clinical trial factors, such as location and funding, relate to racial disparities in participant cohorts.
Methods
A systematic search of ClinicalTrials.gov identified trials related to ischemic and hemorrhagic strokes between 1989 and 2024. Racial representation within trials was evaluated using thresholds from the United States census. Racial disparity was defined by calculating the relative difference between trial cohorts and census benchmarks. Univariate and multivariate analyses were performed to examine the association between study characteristics and racial disparities.
Results
Of the 348 trials reviewed, 169 studies (n=330,862 participants) provided data on racial demographics. Among these, 148 studies (87.6%) demonstrated racial disparity. Regional variation was notable, with Southern (59.5%) and Midwestern (56.8%) states more frequently hosting trials with racial disparity, compared to the Northeast (46.6%) and Western (39.9%) states. Trials with racial disparity also showed lower participant completion rates (80.8%) compared to those without disparity (99.5%). No significant association was found between racial disparity and the trial’s funding sources or the stroke subtype (ischemic vs. hemorrhagic).
Conclusions
This study reveals racial disparities in 87.6% of stroke clinical trials over the past three decades. The findings suggest that these disparities may affect trial completion rates and, by extension, thegeneralizability of outcomes to the broader United States population. Greater efforts are needed to ensure diverse representation in stroke trials, which is essential to translating clinical research into equitable stroke care.
Zitieren
APA
Windhorst, W. H., Weiner, J., Lauinger, A., Naik, A., & Grande, A. (2026). Abstract 783: Gender and Racial Disparities in Stroke Clinical Trials. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_783
Vancouver
Windhorst WH, Weiner J, Lauinger A, Naik A, Grande A. Abstract 783: Gender and Racial Disparities in Stroke Clinical Trials. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_783
BibTeX
@article{Windhorst2026,
author = {Windhorst, W. H. and Weiner, J. and Lauinger, A. and Naik, A. and Grande, A.},
title = {Abstract 783: Gender and Racial Disparities in Stroke Clinical Trials},
journal = {Stroke: Vascular and Interventional Neurology},
year = {2026},
volume = {6},
number = {Suppl_1},
doi = {10.1161/svi270000_783}
}
EUVIMED